.@​dawallach explains why China's rise in drug development could be a bigger disruption to the biopharma industry than AI: "Over the past 5-10 years, China has

.@​dawallach explains why China's rise in drug development could be a bigger disruption to the biopharma industry than AI: "Over the past 5-10 years, China has both invested tremendously in early stage development, like discovery work, and pre-clinical biotech outsourced labor." "In China, what th…